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Introduction
Aortic aneurysm (AA) can be life-threatening and aorta size is the 
best criterion for determining if an intervention is necessary to pre-
vent ruptures, dissections or aneurysm-related deaths.1) However, 
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even large AAs seldom cause symptoms,2)3) although the incidence 
of aortic disease increases with age.4)5) Therefore, it is important for 
clinicians to be cautious in their evaluation of patients at risk.
The etiology of AA differs for each segment of the aorta. Aneu-
rysm of the ascending thoracic aorta (ATA) most often results from 
cystic medial degeneration.2) Atherosclerosis is an infrequent cause 
of aneurysm of ATA, in contrast to that of the descending thoracic 
aorta (DTA) and abdominal aorta, where atherosclerosis plays an 
important role in development of AA.2) Meanwhile, thoracic AAs 
(TAAs) and abdominal AAs (AAAs) share common risk factors, such 
as age and hypertension. Therefore, elderly male subjects with hy-
pertension might be at high risk for both TAA and AAA. 
Efforts to detect high risk populations for coronary heart disease 
(CHD) have been widely applied and coronary calcium measure-
ment using non-contrast computed tomography (CT) is the method 
of choice for assessing cardiovascular risk in asymptomatic sub-
jects.6) Screening for AAA using ultrasound has been recommended 
163In-Jeong Cho, et al.
http://dx.doi.org/10.4070/kcj.2014.44.3.162www.e-kcj.org
in elderly men who are current or past smokers,7) but the screening 
strategy for TAA in elderly subjects is not well-established, even 
though it is a fatal disease.8)9) The more widespread applications of 
cardiac CT and thoracic CT for cardiovascular risk stratification and 
lung cancer screening have made it possible to measure thoracic 
aortic diameter using non-contrast CT, resulting in several success-
ful case reports.10)11)
The purpose of the current study was to use non-contrast CT in a 
prospective manner to explore the prevalence of AAs and determine 
whether screening for CHD and AAs is necessary in a population 
with multiple risk factors for CHD in a Korean population.
 
Subjects and Methods
Study population
Five hundreds and two consecutive Korean male hypertensive 
patients without history of AA were prospectively enrolled from 
June, 2012 to April, 2013 at the outpatient clinic of Severance Car-
diovascular Hospital (Seoul, Korea). Subjects were eligible if they 
were ≥65 years old and had provided signed informed consent. Of 
these 542 patients who had done non-contrast CT of whole aorta, 
15 patients (2.8%) with a history of aortic valve surgery and 30 pa-
tients (5.5%) with a suboptimal CT image were excluded. Most of 
the suboptimal images were those with errors in raw CT data stor-
age, which caused problems of analysis in the sagittal and coronal 
planes using reconstructed images. There were 9 cases of respira-
tion-related motion artifacts. The remaining 496 patients comprised 
the study population. This study was approved by the Institutional 
Review Board of our institution. 
Measurement of clinical variables
Medical history of hypertension, diabetes and dyslipidemia was 
obtained from all patients. Height, weight, and blood pressure were 
measured during their visit. Serum calcium, phosphorus, total cho-
lesterol, low density lipoprotein-cholesterol (LDL-C), high density 
lipoprotein-cholesterol (HDL-C), triglycerides and serum creatinine 
levels were measured after a minimum 12-hour fasting period. Hy-
pertension was defined as systolic blood pressure ≥140 mm Hg and/
or diastolic blood pressure as ≥90 mm Hg or treatment with antihy-
pertensive agents. Diabetes was defined as treatment with hypogly-
cemic agents or insulin, or fasting glucose ≥126 mg/dL. Dyslipid-
emia was defined as any of the following: total cholesterol ≥240 
mg/dL, LDL-C ≥130 mg/dL, HDL-C ≤40 mg/dL, triglyceride ≥150 
mg/dL or treatment with lipid lowering agents. Smoking history was 
obtained from patient interviews or medical records.
CT imaging protocol and analysis
All examinations were performed using an Aquilion ONE 320-row 
CT system (Toshiba Medical Systems, Otawara, Japan). Patients were 
positioned in the supine position on the table. Dual scanograms 
were used for planning the examination and determining the anato-
mical range to be covered. Multiple volumes were placed to cover 
the entire aorta from above the aortic arch to the aortic bifurcation. 
Patients underwent aorta CT with a prospective electrocardiogra-
phy-gating wide-volume protocol (from four to six volumes, accord-
ing to body height). Data were acquired from 40 to 50% of the R-R 
interval. The CT gantry rotation time was 350 ms. The tube voltage 
was 120 kV and the effective tube current was adjusted using the 
adaptive iterative dose reduction three dimensional algorithm. The 
resulting four to six individual volume data sets were automatically 
stitched together immediately after reconstruction to generate one 
CT data set of the whole aorta. All data were reconstructed using a 
standard soft-tissue and lung kernel (FC43). Images were recon-
structed with a slice thickness of 0.5 mm. The CT data sets were re-
constructed at 45% of R-R intervals. Mean radiation dose for pa-
tients undergoing CT of the whole aorta was 7.0±5.3 mSv.
A  B  
Fig. 1. Measurement of aortic diameter in the axial plane. Ascending and descending thoracic aorta (A) and abdominal aorta (B). ATA: ascending thoracic 
aorta, DTA: descending thoracic aorta, AA: abdominal aorta.
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Maximal ascending aorta diameter (ATAMAX) was measured in the 
axial plane from just above the aortic root to the aortic arch perpen-
dicular to the aortic axis. Similarly, maximal descending thoracic 
aorta diameter (DTAMAX) was measured at the DTA distal from the 
aortic arch to the diaphragm level in the same axis (Fig. 1). ATAMAX 
and DTAMAX were confirmed in the sagittal and coronal planes using 
reconstructed images (Fig. 2). Aortic arch diameter was measured 
in the sagittal plane. Maximal thoracic aorta diameter (TAMAX) was 
defined as the largest diameter among ATAMAX, DTAMAX and maximal 
diameter of the aortic arch. Maximal abdominal aortic diameter 
(AAMAX) was defined as the maximal diameter of the abdominal aorta 
from the diaphragm to the first slice superior to the aortic bifurca-
tion. TAA was defined as TAMAX ≥40 mm and AAA was defined as 
AAMAX ≥30 mm.7)12)
Statistical analyses
Distribution of relevant variables was reported either as a per-
centage or as the mean±standard deviation. Groups were compared 
using χ2 statistics for categorical variables. A binary logistic regres-
sion analysis was used to identify risk factors associated with TAA 
and AAA. Variables with a p<0.2 in univariate analysis were includ-
ed in the multiple logistic regression model. Collinearity among ex-
planatory variables was identified using variance inflation factor 
(VIF), and highly correlated variables (VIF>5) were excluded. P<0.05 
were considered statistically significant.
Results
Patient demographics and clinical characteristics are shown in Ta-
ble 1. The mean age was 73 years. Diabetes, dyslipidemia and coro-
A  B  
Fig. 2. Reconstructed images of aorta using non-contrast computed tomography. Reconstructed sagittal (A) and coronal (B) images of aorta.
Table 1. Clinical characteristics of the study population
Variables Value (n=496)
Age (years) 73±5
Male (%) 496 (100)
Height (cm) 166.8±5.7
Weight (kg) 67.3±9.3
BSA (m2) 1.76±0.14
Systolic blood pressure (mm Hg) 125.3±14.9
Diastolic blood pressure (mm Hg) 73.1±10.3
Hypertension (%) 496 (100)
Diabetes mellitus (%) 171 (34.5)
Dyslipidemia (%) 318 (64.1)
Current/past smoker (%) 364 (73.4)
Medications (%)
Diuretics 116 (23.4)
Beta blocker 232 (46.8)
Calcium channel blocker 307 (61.9)
ACEi/ARB 27 (73.0)
Statin 298 (60.1)
Laboratory findings (g/mL)
Calcium 9.0±0.4
Phosphorus 3.4±0.6
Creatinine 1.21±1.06
Total cholesterol 151.5±32.1
LDL-C 87.8±29.4
HDL-C 43.9±11.0
BSA: body surface area, AVR: aortic valve replacement, ACEi: angiotensin 
converting enzyme inhibitor, ARB: aldosteron receptor blocker, LDL-C: low 
density lipoprotein-cholesterol, HDL-C: high density lipoprotein-cholesterol
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nary artery disease were observed in 171 patients (34.5%), 318 pa-
tients (64.1%) and 256 patients (51.6%), respectively. Three hundred 
and sixty-four patients (73.4%) had a history of smoking. Mean 
systolic and diastolic blood pressure were 125.3±14.9 mm Hg and 
73.1±14.9 mm Hg. Mean diameter of ATAMAX, DTAMAX, TAMAX, and AAMAX 
was 38.4±4.0 mm, 28.5±3.0 mm, 38.9±4.0, and 23.0±5.5 mm, re-
spectively. Fig. 3 shows a histogram of TAMAX and AAMAX. The preva-
lence of TAA and AAA was 36.5% (181/496) and 6.0% (30/496), re-
spectively. There were 16 patients (3.2%) who had TAA and AAA 
simultaneously. However, prevalence of AA suitable for an indica-
tion for intervention according to current guidelines (TAMAX ≥55 mm 
and AAMAX ≥60 mm)2) was very low in this study. Those who were 
indicated for intervention were seen only in one case of the TAA 
group and one case of the AAA group. 
Prevalence of TAA was 64.6% in patients with AAA and 40.0% in 
patients without AAA. Patients with AAA had a higher occurrence 
of TAA compared with those without AAA (p=0.010) (Fig. 4). Fig. 5 
demonstrates difference of prevalence of AA according to history of 
smoking. There was no significant difference in prevalence of TAA 
between nonsmokers and those who had a history of smoking or 
were current smokers. In contrast, prevalence of AAA was signifi-
Fig. 3. Histogram of maximal thoracic (A) and abdominal aorta (B). Red lines indicate maximal thoracic aorta of 40 mm and maximal abdominal aorta of 
30 mm. TAMAX: maximal thoracic aorta, AAMAX: maximal abdominal aorta.
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Fig. 4. Prevalence of thoracic aortic aneurysm in patients with and with-
out abdominal aortic aneurysm. TAA (-), patients without thoracic aortic 
aneurysm; TAA (+), patients with thoracic aortic aneurysm; AAA (+), pa-
tients with abdominal aortic aneurysm; AAA (-), patients without abdomi-
nal aortic aneurysm.
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Fig. 5. Prevalence of thoracic aortic aneurysm (A) and abdominal aortic aneurysm (B) according to history of smoking. Smoking (+), current or past smok-
er; Smoking (-), never smoked.
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Table 2. Logistic regression analysis of variables as determinants of thoracic aortic aneurysm and abdominal aortic aneurysm
Variables
Univariate Multivariate
Odds ratio (95% CI) p Odds ratio (95% CI) p
TAA (n=181)
 Age 1.030 (0.994–1.068) 0.103 1.059 (1.018–1.101) 0.005
 Diabetes mellitus 0.707 (0.478–1.046) 0.083 0.705 (0.466–1.068) 0.099
 Dyslipidemia 0.640 (0.439–0.934) 0.021 0.621 (0.418–0.923) 0.018
 Current/past smoker 0.864 (0.641–1.165) 0.337
 BSA 9.070 (2.373–34.67) 0.001 11.92 (2.787–50.97) 0.001
 Systolic BP 1.008 (0.996–1.020) 0.205
 Diastolic BP 1.029 (1.010–1.048) 0.096 1.029 (1.009–1.049) 0.004
 HDL-C 0.985 (0.968–1.003) 0.096
 LDL-C 1.004 (0.998–1.011) 0.209
 Creatinine 1.014 (0.860–1.195) 0870
Presence of AAA 2.735 (1.294–5.856) 0.009 3.070 (1.398–6.754) 0.005
Use of diuretics 1.174 (0.766–1.800) 0.461
Use of beta blocker 1.025 (0.711–1.478) 0.896
Use of CCB 1.354 (0.925–1.984) 0.119 1.310 (0.876–1.959) 0.189
Use of ACEi/ARB 0.918 (0.622–1.354) 0.665
Use of Statin 0.708 (0.488–1.027) 0.069
AAA (n=30)
 Age 1.016 (0.947–1.091) 0.654
 Diabetes mellitus 0.944 (0.432–2.065) 0.885
 Dyslipidemia 2.327 (0.933–5.804) 0.060 2.792 (1.091–7.143) 0.032
Current/past smoker 3.237 (1.022–10.80) 0.045 4.074 (1.160–14.31) 0.028
 BSA 2.288 (0.168–31.21) 0.535
 Systolic BP 0.992 (0.968–1.018) 0.552
 Diastolic BP 0.988 (0.954–1.025) 0.532
 HDL-C 0.967 (0.929–1.006) 0.099
 LDL-C 0.999 (0.986–1.012) 0.843
 Creatinine 1.185 (0.969–1.450) 0.098 1.228 (0.993–1.518) 0.058
Presence of TAA 2.753 (1.294–5.856) 0.009 3.367 (1.550–7.313) 0.002
Use of diuretics 0.994 (0.415–2.379) 0.989
Use of beta blocker 1.759 (0.829–3.735) 0.141
Use of CCB 1.240 (0.568–2.711) 0.589
Use of ACEi/ARB 1.122 (0.502–2.509) 0.779
Use of Statin 2.270 (0.955–5.397) 0.064
Both TAA and AAA (n=16)
 Age 0.998 (0.905–1.101) 0.973
 Diabetes mellitus 0.857 (0.293–2.508) 0.778
 Dyslipidemia 1.696 (0.539–5.340) 0.367
Current/pastsmoker 2.440 (0.547–10.89) 0.182 1.286 (0.556–2.975) 0.556
 BSA 6.541 (0.196–218.5) 0.294
 Systolic BP 1.002 (0.969–1.035) 0.930
 Diastolic BP 1.013 (0.966–1.063) 0.592
 HDL-C 0.978 (0.928–1.031) 0.411
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cantly higher in current/past smokers compared to nonsmokers 
(p=0.046). Of the 365 current/past smokers, AAA was found in 27 
patients (7.4%), but of the 124 non-smokers, AAA was observed in 
only three patients (2.4%), and there were no nonsmokers with a 
large AAA (> 40 mm).
Determinants for TAA, AAA and both TAA and AAA are shown in 
Table 2. In the multivariate logistic regression analysis, determinants 
for TAA were age {odds ratio (OR) 1.059, 95% confidence interval 
(CI) 1.018–1.101, p=0.005}, absence of dyslipidemia (OR 0.621, 95% 
CI 0.418–0.923, p=0.018), body surface area (OR 11.92, 95% CI 
2.787–50.97, p=0.001), diastolic blood pressure (OR 1.029, 95% CI 
1.009–1.049, p=0.004) and presence of AAA (OR 3.070, 95% CI 
1.398–6.754, p=0.005). In contrast, AAA was independently associ-
ated with presence of dysplipidemia (OR 2.792, 95% CI 1.091–7.143, 
p=0.032), current/past smokers (OR 4.074, 95% CI 1.160–14.31, 
p=0.028) and presence of TAA (OR 3.367, 95% CI 1.550–7.313, 
p=0.002). However, there were no independent determinants for 
presence of both TAA and AAA.
 
Discussion
Aortic size is critical to key decisions regarding management of 
AAs.12) This study evaluated the entire aorta diameter, from the tho-
racic aorta to the abdomen aorta just above the iliac bifurcation, us-
ing axial images of non-contrast CT scans in a population with mul-
tiple risk factors for both CHD and AA. Prevalence of TAA was sig-
nificant in this population. The study population included high-risk 
individuals, but blood pressure and serum lipids were well con-
trolled in most patients, as indicated by blood pressure and labora-
tory test results. Nevertheless, prevalence of TAA was considerably 
high and TAA was associated with various clinical factors including 
older age, larger BSA and higher diastolic blood pressure. Interest-
ingly, TAA was associated with the absence of dyslipidemia, while 
AAA was significantly associated with the presence of dyslipidemia. 
One possible explanation might be that the etiology of AAs differs 
between ascending and descending aorta.1) That is, above the liga-
mentumarteriosum the disease is non-atherosclerotic, while below 
the ligamentumarteriosum arteriosclerosis is abundant.1) Therefore, 
TAA might not be associated with dyslipidemia. Another explana-
tion for the conflicting results might be that the mean values of to-
tal cholesterol, LDL-C and HDL-C were almost within normal limits, 
suggesting the serum lipids were well controlled in most patients. 
In addition, since the current study was performed at a tertiary re-
ferral hospital, many of the patients were taking statins for the pri-
mary or secondary prevention for coronary artery disease, not for 
the treatment of dyslipidemia. Therefore, effects of high lipids on 
atherosclerosis might be minimized in the studied population and 
result in conflicting outcomes. Therefore, further studies are need-
ed to clarify the relationship among TAA, AAA, dyslipidemia, serum 
cholesterol and statin therapy.
Thoracic aortic aneurysm was more prevalent in patients with 
AAA compared to those without AAA, even after adjusting for mul-
tiple confounding factors. However, risk factors for TAA and AAA 
were different. In addition, more than one-third of the study sub-
jects had a TAA, and it was remarkably more prevalent than AAA 
among high-risk subjects in the current study, in contrast to previ-
ous reports that AAA is more prevalent than TAA.1) TAA prevalence 
continuously increases,13) and is thought to be related to increased 
age and hypertension in the general population. The current study 
focused on elderly patients, which may explain the discrepancy. 
However, most TAAs had a diameter <50 mm, which is not large 
enough to indicate a need for immediate intervention. Therefore, the 
clinical implications of the high prevalence of TAA need further 
evaluation, since TAAs are known to be an indolent process and to 
grow very slowly, at approximately 0.1 cm per year.9)14) Future stud-
ies should establish a method for aortic screening for TAA and strat-
egies for conservative as well as surgical management in elderly 
hypertensive patients.
Table 2. Continued
Variables
Univariate Multivariate
Odds ratio (95% CI) p Odds ratio (95% CI) p
 LDL-C 0.999 (0.987–1.017) 0.914
 Creatinine 1.056 (0.730–1.528) 0.773
Use of diuretics 0.450 (0.102–2.043) 0.306
Use of beta blocker 1.138 (0.420–3.083) 0.799
Use of CCB 1.871 (0.595–5.889) 0.284
Use of ACEi/ARB 0.790 (0.282–2.212) 0.653
Use of statin 2.204 (0.783–5.570) 0.188 2.069 (0.654–6.542) 0.216
CI: confidential interval, TAA: thoracic aortic aneurysm, AVR: aortic valve replacement, BSA: body surface area, BP: blood pressure, HDL-C: high density li-
poprotein-cholesterol, LDL-C: low density lipoprotein-cholesterol, AAA: abdominal aortic aneurysm, ACEi: Angiotensin converting enzyme inhibitor, ARB: 
aldosteron receptor blocker, CCB: calcium channel blocker
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Previous studies consistently demonstrated a relationship be-
tween smoking and AAA.11) The present study, which involved a high-
risk population of Asian males, found that AAA was independently 
associated with smoking history in addition to dyslipidemia. More-
over, prevalence of AAA was 2.4% among nonsmokers, which is 
very low compared to previous studies involving Caucasians.15)16) In 
addition, none of the nonsmokers had a large AAA (>40 mm). In 
population-based screening studies in Japan, AAA was rarely en-
countered17)18) and the prevalence of AAA was also reportedly low in 
Chinese populations, even in patients with severe coronary artery 
disease.19) This suggests that race influences AAA prevalence and 
that Asians generally have a low prevalence of AAA. The present 
study also reported a low prevalence of AAA in an Asian population 
and reinforced the impact of smoking on AAA. These results high-
light the need to clearly define the usefulness of routine screening 
for AAA among Asian non-smokers. 
Limitations
The primary limitation of this study is that a CT scan with axial 
images could not properly evaluate the very proximal portion of the 
ascending aorta including the aortic root. In addition, even in the 
sagittal and coronal planes, aortic root diameter could not be accu-
rately measured using non-contrast CT due to the complexity of the 
structures surrounding the aortic root. Therefore, different imag-
ing modalities are needed to accurately detect aortic root aneu-
rysms. This study was performed in a population of elderly Asian 
males with hypertension at high risk for cardiovascular disease. 
Therefore, the results of the current study cannot be applied to fe-
males, other ethnicities, or groups with a low-risk of cardiovascular 
disease.
Conclusion
The prevalence of AA was significant and TAA was more prevalent 
than AAA in elderly Korean males with hypertension who had mul-
tiple risk factors for CHD and AA. Future research should establish 
distinct screening strategies for TAA and AAA according to risk fac-
tors and ethnicity.
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